Interaction of a series of beta-adrenergic blocking drugs with rat hepatic microsomal monooxygenase.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000526:Alprenolol / Q000378:metabolism; D000818:Animals; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D066298:In Vitro Techniques; D008055:Lipids; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology*; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D009249:NADP / Q000378:metabolism; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000378:metabolism*; D011433:Propranolol / Q000378:metabolism; D051381:Rats
D000319:Adrenergic beta-Antagonists; D008055:Lipids; D009249:NADP; D000526:Alprenolol; D003577:Cytochrome P-450 Enzyme System; D011433:Propranolol; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases